Baseline Troponin T Levels Modulate the Effects of ICD Shocks on All-Cause Mortality.
暂无分享,去创建一个
E. Guallar | G. Tomaselli | J. Marine | D. Spragg | V. Nauffal | A. Cheng | Yiyi Zhang | Barbara Butcher | E. Blasco-Colmenares | Sanaz Norgard
[1] Yiyi Zhang,et al. Protein Biomarkers Identify Patients Unlikely to Benefit From Primary Prevention Implantable Cardioverter Defibrillators: Findings From the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD) , 2014, Circulation. Arrhythmia and electrophysiology.
[2] P. Heidenreich,et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. , 2013, Journal of the American College of Cardiology.
[3] D. Mark,et al. Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.
[4] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[5] D. Wyse,et al. Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2001, Circulation.